CN101537041B - Chinese medicinal composition for treating hepatitis A and hepatitis B - Google Patents
Chinese medicinal composition for treating hepatitis A and hepatitis B Download PDFInfo
- Publication number
- CN101537041B CN101537041B CN2009101025363A CN200910102536A CN101537041B CN 101537041 B CN101537041 B CN 101537041B CN 2009101025363 A CN2009101025363 A CN 2009101025363A CN 200910102536 A CN200910102536 A CN 200910102536A CN 101537041 B CN101537041 B CN 101537041B
- Authority
- CN
- China
- Prior art keywords
- hepatitis
- portions
- chinese medicinal
- medicinal composition
- pathogens
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 15
- 208000005252 hepatitis A Diseases 0.000 title claims abstract description 9
- 208000002672 hepatitis B Diseases 0.000 title claims abstract description 8
- 239000003814 drug Substances 0.000 claims abstract description 16
- 241001533116 Pittosporum glabratum Species 0.000 claims abstract description 7
- 241000628997 Flos Species 0.000 claims description 5
- 239000008280 blood Substances 0.000 abstract description 11
- 210000004369 blood Anatomy 0.000 abstract description 11
- 210000004185 liver Anatomy 0.000 abstract description 9
- 208000004880 Polyuria Diseases 0.000 abstract description 4
- 230000035619 diuresis Effects 0.000 abstract description 4
- 244000052769 pathogen Species 0.000 abstract description 4
- 235000008495 Chrysanthemum leucanthemum Nutrition 0.000 abstract description 3
- 229940079593 drug Drugs 0.000 abstract description 3
- 210000000952 spleen Anatomy 0.000 abstract description 3
- 244000219416 Hypericum japonicum Species 0.000 abstract description 2
- 210000003734 kidney Anatomy 0.000 abstract description 2
- 238000002360 preparation method Methods 0.000 abstract description 2
- 210000001835 viscera Anatomy 0.000 abstract description 2
- 238000005728 strengthening Methods 0.000 abstract 2
- 208000024891 symptom Diseases 0.000 abstract 2
- 244000035851 Chrysanthemum leucanthemum Species 0.000 abstract 1
- 206010062717 Increased upper airway secretion Diseases 0.000 abstract 1
- 206010037660 Pyrexia Diseases 0.000 abstract 1
- 244000303286 Stachys officinalis Species 0.000 abstract 1
- 235000009225 Stachys officinalis Nutrition 0.000 abstract 1
- 240000001949 Taraxacum officinale Species 0.000 abstract 1
- 235000005187 Taraxacum officinale ssp. officinale Nutrition 0.000 abstract 1
- 238000001816 cooling Methods 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- 208000026435 phlegm Diseases 0.000 abstract 1
- 230000001105 regulatory effect Effects 0.000 abstract 1
- 230000003014 reinforcing effect Effects 0.000 abstract 1
- 231100000331 toxic Toxicity 0.000 abstract 1
- 230000002588 toxic effect Effects 0.000 abstract 1
- 208000006454 hepatitis Diseases 0.000 description 13
- 231100000283 hepatitis Toxicity 0.000 description 10
- 239000000796 flavoring agent Substances 0.000 description 6
- 235000019634 flavors Nutrition 0.000 description 6
- 201000010099 disease Diseases 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 231100000252 nontoxic Toxicity 0.000 description 3
- 230000003000 nontoxic effect Effects 0.000 description 3
- 231100000614 poison Toxicity 0.000 description 3
- 230000001737 promoting effect Effects 0.000 description 3
- 241000208365 Celastraceae Species 0.000 description 2
- 244000192528 Chrysanthemum parthenium Species 0.000 description 2
- 235000000604 Chrysanthemum parthenium Nutrition 0.000 description 2
- 235000000336 Solanum dulcamara Nutrition 0.000 description 2
- 230000000202 analgesic effect Effects 0.000 description 2
- 235000009508 confectionery Nutrition 0.000 description 2
- 208000001848 dysentery Diseases 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 235000008384 feverfew Nutrition 0.000 description 2
- 239000000706 filtrate Substances 0.000 description 2
- 208000019423 liver disease Diseases 0.000 description 2
- 238000011084 recovery Methods 0.000 description 2
- 230000008961 swelling Effects 0.000 description 2
- 239000003440 toxic substance Substances 0.000 description 2
- 206010003445 Ascites Diseases 0.000 description 1
- 206010008909 Chronic Hepatitis Diseases 0.000 description 1
- 240000005250 Chrysanthemum indicum Species 0.000 description 1
- 235000018959 Chrysanthemum indicum Nutrition 0.000 description 1
- 201000004624 Dermatitis Diseases 0.000 description 1
- 201000000297 Erysipelas Diseases 0.000 description 1
- 241001489978 Eupolyphaga Species 0.000 description 1
- 241000222336 Ganoderma Species 0.000 description 1
- 208000007882 Gastritis Diseases 0.000 description 1
- 208000005577 Gastroenteritis Diseases 0.000 description 1
- 208000037319 Hepatitis infectious Diseases 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 206010023126 Jaundice Diseases 0.000 description 1
- 241001092092 Pittosporaceae Species 0.000 description 1
- 241001092090 Pittosporum Species 0.000 description 1
- 206010035664 Pneumonia Diseases 0.000 description 1
- 206010053476 Traumatic haemorrhage Diseases 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 231100000354 acute hepatitis Toxicity 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000000845 anti-microbial effect Effects 0.000 description 1
- 230000000840 anti-viral effect Effects 0.000 description 1
- 208000010668 atopic eczema Diseases 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 229940126678 chinese medicines Drugs 0.000 description 1
- 201000001352 cholecystitis Diseases 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 208000019425 cirrhosis of liver Diseases 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 230000003179 granulation Effects 0.000 description 1
- 238000005469 granulation Methods 0.000 description 1
- 230000002650 habitual effect Effects 0.000 description 1
- 230000002440 hepatic effect Effects 0.000 description 1
- 241000411851 herbal medicine Species 0.000 description 1
- 239000008361 herbal raw material Substances 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000002458 infectious effect Effects 0.000 description 1
- 208000018191 liver inflammation Diseases 0.000 description 1
- 208000004396 mastitis Diseases 0.000 description 1
- 231100000957 no side effect Toxicity 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 210000002826 placenta Anatomy 0.000 description 1
- 230000007096 poisonous effect Effects 0.000 description 1
- 208000020016 psychiatric disease Diseases 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 238000012827 research and development Methods 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 208000019206 urinary tract infection Diseases 0.000 description 1
- 230000003612 virological effect Effects 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention relates to a Chinese medicinal composition for treating hepatitis A and hepatitis B. The Chinese medicinal composition comprises the components with the following dosage: 8-11 portions of hypericum japonicum, 6-9 portions of herb of oblongleaf betony, 4-7 portions of wild chrysanthemum, 5-8 portions of dandelion and 7-11 portions of pittosporum glabratum var. neriifolium. The Chinese medicinal composition is not only capable of relieving the secondary symptoms, namely dispelling wind and reducing fever, cooling blood and eliminating dampness, diuresis and dissipating blood stasis, dispelling phlegm and blood stasis, but also capable of relieving the primary symptoms, namely soothing the liver, nourishing the spleen, tonifying the kidney, boosting qi and replenishing essence, eliminating pathogens but not being harmful to body, and strengthening healthy energy but not keeping pathogens, thus achieving dispelling pathogens and strengthening body resistance, mild reinforcing yin and yang, and regulating viscera to lead qi and blood to be smooth. The Chinese medicinal composition has the advantages of precise and appropriate drug selection, short treatment period, no toxic and side effects, simple preparation process, low cost and resources superiority in the Miao nationality and Dong nationality regions.
Description
Technical field
The present invention relates to a kind of Chinese medicine composition for the treatment of hepatitis, in particular to a kind of Chinese medicine composition for the treatment of hepatitis A and hepatitis B that with the Chinese herbal medicine is preparation of raw material.
Background technology
Hepatitis is that a kind of viral infectious is again a kind of cure diseases that is difficult to, it is divided into type hepatitis such as first, second, third, fourth, wherein modal is hepatitis A and hepatitis B, the herbal species for the treatment of hepatitis simultaneously is various, as application number is 011399800.5 Chinese patent, and it is formulated mainly to comprise 24 flavor Chinese medicines such as Carapax Trionycis, Squama Manis, Artemisia anethoicles Mattf, Radix Salviae Miltiorrhizae, Rhizoma Picrorhizae, Eupolyphaga Seu Steleophaga, Ganoderma.This prescription is based on soothing the liver wet, eliminating toxic substances to remove stasis, the anti-inflammatory analgesic of leading, and it is normal that every index is recovered, and makes hepatopathy transference cure at short notice, and is aided with the benefiting qi and nourishing blood easing the affected liver, recovers body constitution, strengthens resistance against diseases.And for example application number is 00121528.0 Chinese patent, mainly form by plumage pool, eel-like figure worm, Placenta Hominis, thorn Fructus Jujubae etc., this prescription adapts to the variety classes hepatopathy by the increase and decrease to compatibility and dosage, as acute hepatitis, chronic hepatitis, liver cirrhosis and hepatic ascites are treated, and get well faster in order to make the hepatopath, and people are still in the novel drugs that continues research and development treatment hepatitis.
Summary of the invention
The object of the present invention is to provide a kind of new to the equal effective Chinese medicine composition of treatment hepatitis A and hepatitis B, for hepatitis patient palliates the agonizing sufferings.
Solution of the present invention be the inventor on prescription handed down from one's ancestors basis, fully be beneficial to habitual herbal raw material of the Dong nationality and clinical practice for many years, the prescription that preferably comes out.
The present invention is a kind of, and to treat the Chinese medicinal composition and the consumption thereof of hepatitis A and hepatitis B as follows: Herba Hyperici Japonici 8～11, Herba stachydis oblongifoliae 6～9, Flos Chrysanthemi Indici 4～7, Herba Taraxaci 5～8, Pittosporum glabratum Lindl. var. neriifolium Rehd.et Wils. 7～11.
In the above-mentioned Chinese medicine, Herba Hyperici Japonici Hypericum japonicum Thunb., nature and flavor; Bitter sweet, cold, nontoxic, function cures mainly; Clearing away heat-damp and promoting diuresis, subduing swelling and detoxicating.Control infectious hepatitis, dysentery.Herba stachydis oblongifoliae Stachysoplongifolia Benth. is the herb or the root of the long garden of labiate leaf Herba Stachydis Japonicae.Nature and flavor; Acrid in the mouth is little sweet, nontoxic.Function cures mainly; Invigorating the spleen and replenishing QI, hemostasia and promoting granulation.Control chronic dysentery; Weakness and traumatic hemorrhage after curing the disease.Flos Chrysanthemi Indici Chrysanthemum indicum Li is the head inflorescence of feverfew Herba Dendranthematis indici, nature and flavor; Toil, cool, slightly poisonous.Function cures mainly; Wind and heat dispersing, removing heat from blood dampness, subduing swelling and detoxicating have blood pressure lowering and antiviral, antimicrobial effect, control gastroenteritis, pneumonia, hypertension, erysipelas, eczema etc.Herba Taraxaci TaraxaeummonolicumEland.-Mazz. is the whole herb with root of feverfew Herba Taraxaci.Nature and flavor; Bitter sweet, cold, nontoxic.Function cures mainly; Heat-clearing and toxic substances removing, the diuresis eliminating stagnation, the treating the liver inflammation, gastritis, cholecystitis, acute mastitis, urinary tract infection etc. are to go into stomach into liver, the key medicine of analgesic removing heat from blood.Pittosporum glabratum Lindl. var. neriifolium Rehd.et Wils. Pittosporum perryanum Govdavar.linerfolium Chang et yan. is the root and the stem of Pittosporaceae plant Pittosporum glabratum Lindl. var. neriifolium Rehd.et Wils..Nature and flavor; Little sweet, delicate fragrance.Function cures mainly; Removing summer-heat liver and gall pathogenic heat, the soothing the liver stasis of blood, the removing dampness jaundice eliminating separated, promoting blood circulation and detoxication, sharp liver protects the liver, and the cytopathy that hepatitis virus resisting causes can be turned out cloudy until recovery from illness fast to " great three positive ", " small three positive " that hepatitis causes.Above drug reference document (seeing the new medical college volume in Jiangsu " Chinese medicine voluminous dictionary ") and " Guizhou flora ".
The ultimate principle of above-mentioned traditional Chinese medicine composition for treating hepatitis is: can wind and heat dispersing, removing heat from blood dampness, diuresis eliminating stagnation, dispel the mental disorder blood stasis and control its mark, again can the kidney invigorating of soothing the liver reason spleen, the QI invigorating replenishing essence consolidates Zhi Qiben, eliminating evil and just do not hinder, set upright and do not stay heresy, reach vital QI recovered after pathogens eliminated, negative and positive are flat secret, internal organs and accent, the QI and blood smoothness.
The advantage that the present invention realizes is; Select YAOJING to work as, treatment cycle is short, has no side effect, and processing technology is simple, and cost is low, in Miao ethnic group, the Dong nationality area resources advantage is arranged.
The specific embodiment:
Embodiment is with Herba Hyperici Japonici 9, Herba stachydis oblongifoliae 8, night Flos Chrysanthemi 7, Herba Taraxaci 8, Pittosporum glabratum Lindl. var. neriifolium Rehd.et Wils. 10.Be equipped with medicine according to formula proportion, soaked 4 hours, stir, heat decoction then, extract with pure water, fine straining gets filtrate, and the patient obeys this filtrate 100ml/ time, three times on the one, " great three positive ", " small three positive " that hepatitis were caused in 1～3 month can be turned out cloudy until recovery from illness fast.
Claims (2)
1. Chinese medicine composition for the treatment of hepatitis A and hepatitis B is characterized in that this Chinese medicine composition is made up of the weight portion of Herba Hyperici Japonici 8-11, Herba stachydis oblongifoliae 6-9, Flos Chrysanthemi Indici 4-7, Herba Taraxaci 5-8, Pittosporum glabratum Lindl. var. neriifolium Rehd.et Wils. 7-11.
2. Chinese medicine composition according to claim 1 is characterized in that this Chinese medicine composition is made up of Herba Hyperici Japonici 9, Herba stachydis oblongifoliae 8, Flos Chrysanthemi Indici 7, Herba Taraxaci 8, Pittosporum glabratum Lindl. var. neriifolium Rehd.et Wils. 10 weight portions.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2009101025363A CN101537041B (en) | 2009-04-30 | 2009-04-30 | Chinese medicinal composition for treating hepatitis A and hepatitis B |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2009101025363A CN101537041B (en) | 2009-04-30 | 2009-04-30 | Chinese medicinal composition for treating hepatitis A and hepatitis B |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN101537041A CN101537041A (en) | 2009-09-23 |
| CN101537041B true CN101537041B (en) | 2011-04-27 |
Family
ID=41120582
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN2009101025363A Expired - Fee Related CN101537041B (en) | 2009-04-30 | 2009-04-30 | Chinese medicinal composition for treating hepatitis A and hepatitis B |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN101537041B (en) |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1145240A (en) * | 1996-05-31 | 1997-03-19 | 黄英秀 | Medicinal compsn. for prevention of Aids virus and cancer |
-
2009
- 2009-04-30 CN CN2009101025363A patent/CN101537041B/en not_active Expired - Fee Related
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1145240A (en) * | 1996-05-31 | 1997-03-19 | 黄英秀 | Medicinal compsn. for prevention of Aids virus and cancer |
Also Published As
| Publication number | Publication date |
|---|---|
| CN101537041A (en) | 2009-09-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101390994B (en) | Medicine for treating herpes zoster | |
| CN1286518C (en) | Chinese medicinal prescription for treating gastropathy | |
| CN103860958A (en) | Traditional Chinese medicinal composition for treating acne | |
| CN103920074A (en) | Traditional Chinese medicine composition for treating hepatitis B | |
| CN101757504A (en) | Formula of traditional Chinese medicine for treating chronic rhinitis | |
| CN1692939A (en) | Traditional Chinese medicine pill for treating hepatitis B, and its prepn. method | |
| CN102526459B (en) | Traditional Chinese medicine composition for treating nasosinusitis and preparation method thereof | |
| CN1517119A (en) | Medicinal wine or liquid for treating cold | |
| CN101537041B (en) | Chinese medicinal composition for treating hepatitis A and hepatitis B | |
| CN1459308A (en) | Series medicines for treating headache | |
| CN1857510A (en) | Medicine for treating coronary heart disease | |
| CN103156915A (en) | Medicine composition used for treating hepatitis C | |
| CN106511671A (en) | Medicinal liquor for treating hyperostosis, rheumatism and gout disease | |
| CN101940723A (en) | Chinese medicinal preparation for treating pyelonephritis | |
| CN1413715A (en) | Chinese drugs for treating chronic rhinitis | |
| CN1903329A (en) | Traditional Chinese medicine for treating chronic periodontitis | |
| CN110279823B (en) | Traditional Chinese medicine composition for treating dengue fever and preparation method thereof | |
| CN1059574C (en) | Chinese medicine preparation | |
| CN1066951C (en) | Traditional Chinese powder medicine for hepatosis | |
| CN106692588A (en) | Traditional Chinese medicine formula for treating liver cirrhosis | |
| CN1651049A (en) | Chinese medicinal preparation for treating pelvis nephritis | |
| CN1104248C (en) | Chinese medicine for treating tuberculosis and hepatitis | |
| CN1231246C (en) | Medicinal liquid for activating meridians | |
| CN1651053A (en) | Chinese medicinal preparation for treating glomerulus nephritis | |
| CN114377090A (en) | Specific Chinese medicine capsule for treating hepatitis B |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C17 | Cessation of patent right | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20110427 Termination date: 20140430 |